Poland Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

The publisher, the industry analysis specialist, has released its latest report “Poland Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Poland. It identifies the key trends in the country's healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by the publisher's team of industry experts.

The Polish pharmaceutical market is one of the largest emerging markets in Central and Eastern Europe (CEE), with advanced government-supported infrastructure, increased foreign business investments, improved regulatory compliance, and well-developed logistics. The Polish pharmaceutical market, based on production value, was worth $6.3 billion in 2013, which increased at a Compound Annual Growth Rate (CAGR) of 5.3% to $8.6 billion in 2019. The market value is expected to increase further and is forecast to reach $12.4 billion by 2026. In 2016, the medical devices market in Poland was worth $3.6 billion, which increased at a CAGR of 5.7% to $4.8 billion in 2021. The medical device market is expected to grow at a CAGR of 5.7% from 2022 to reach $6.6 billion in 2027. In 2021, the Polish government launched the National Health Program 2021-25, aiming to extend the lives of citizens and minimize the burden of noncommunicable illnesses by lowering the risk factors. Preventing and managing overweight, obesity, and poor mental health are among the operational goals of the program.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Poland, and includes:

An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
Profiles and SWOT analyses of the major players in the pharmaceutical market: Bioton, Sanofi, Novartis, GSK, and Roche.
Profiles and SWOT analyses of the major players in the medical device market: Fresenius, Medtronic, Abbott, Stryker, and MedicALgorithmics.
An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country's healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices.
Detailed analysis of the country's healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure.
An overview of the opportunities for and challenges to growth in the Poland healthcare market.

Reasons to Buy

This report will enhance your decision-making capability by allowing you to:

Develop business strategies by understanding the trends shaping and driving Poland healthcare market
Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Poland healthcare market in the future
Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors' performance
Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

1. Table of Contents

1.1 List of Figures
1.2 List of Tables

2. Executive Summary

2.1 Executive Summary
2.2 Key Highlights - Facts about the Poland Healthcare Market
2.3 Key Highlights: Healthcare Startups in Poland
2.4 Key Events: Poland Healthcare Timeline, 2016-22
2.5 Key Events: Poland Pharmaceutical Market
2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2020-22
2.7 Key Events: Mergers and Acquisitions
2.8 Country Profile, Poland, 2021

3. Overview of Pharmaceutical Market

3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Exports
3.3 Pharmaceutical Market - Imports
3.4 Pharmaceutical Market - Supply Channels, Poland
3.5 Pharmaceutical Market - Market Segments
3.6 Pharmaceutical Market - Market Segments, Generics, Poland
3.7 Pharmaceutical Market - Market Segments, Biologics and Biosimilars, Poland
3.8 Pharmaceutical Market - Market Segments, Over-the-Counter Medicines, Poland
3.9 COVID-19 Epidemiology, Poland
3.10 COVID-19 Impact and Developments in the Healthcare Market, Poland
3.11 COVID-19 Clinical Trials Landscape, Poland
3.12 Pharmaceutical Market - Major Players

4. Overview of Medical Devices Market

4.1 Medical Device Market - Overview
4.2 Medical Device Market - Major Segments
4.3 Medical Device Market - Hospital Supplies Market
4.4 Medical Device Market - Cardiovascular Devices Market
4.5 Medical Device Market - General Surgery Market
4.6 Medical Device Market - Orthopedic Devices Market
4.7 Medical Device Market - Diabetes Care Devices Market
4.8 Medical Devices Market - Diagnostics Market
4.9 Medical Devices Market - Major Players

5. Pharmaceutical and Medical Devices Market - Drivers and Barriers

5.1 Drivers
5.2 Barriers

6. Deal Analysis

6.1 Deal Analysis: Pharmaceutical Market, Poland, 2019-22
6.2 Deal Analysis: Medical Device Market, Poland, 2019-22

7. HealthTech Landscape

7.1 HealthTech Landscape, Poland
7.2 HealthTech Deals Landscape, Poland
7.3 Key HealthTech Deals, Poland
7.4 Adoption of Technology in Healthcare, Poland
7.5 Regulatory Scenario Covering Use of Technology in Healthcare, Poland
7.6 HealthTech Landscape: Benefits and Risks, Poland

8. Market Access

8.1 Overview of Healthcare System, Poland
8.2 Reimbursement Process, Poland
8.3 Overview of Insurance Providers, Poland
8.4 Healthcare Spending and Prescription Drug Price Trend, Poland
8.5 Pricing Policies, Poland
8.6 Market Access: Key Events Timeline, Poland, 2010-21
8.7 Regulatory Landscape, Poland
8.7.1 Marketing Authorization for Pharmaceutical Products, Poland
8.7.2 Marketing Authorization for Pharmaceutical Products (Centralized Procedure), Poland
8.7.3 Marketing Authorization for Pharmaceutical Products (Decentralized Procedure), Poland
8.7.4 Marketing Authorization for Pharmaceutical Products (Mutual Recognition Procedure), Poland
8.7.5 Marketing Authorization for Medical Devices, Poland
8.7.6 Intellectual Property Rights, Patent, Poland
8.7.7 Intellectual Property Rights, Trademark, Poland
8.7.8 Clinical Trial Regulation Process, Poland
8.7.9 Pharmaceutical Clinical Trials Landscape, Poland
8.7.10 Medical Device Clinical Trials Landscape, Poland
8.7.11 Pharmaceutical Manufacturing and Licensing, Poland
8.7.12 Pharmaceutical Export and Import, Poland
8.7.13 Pharmaceutical Advertising Regulations, Poland
8.7.14 Pharmacy Regulations, Poland
8.7.15 Labeling and Packaging Regulations, Poland

9. Country Healthcare Landscape

9.1 Healthcare Policy Highlights, Poland
9.2 Healthcare Facilities, Poland
9.3 Healthcare Parameters, Poland
9.4 Life Expectancy and Immunization Rate, Poland
9.5 Environmental Health, Poland
9.6 Healthcare Personnel, Poland
9.7 Disease Burden, Poland
9.8 Healthcare Expenditure, Poland

10 Trade Associations, Poland11 Trade Fairs, Poland12 Opportunities and Challenges

13 Appendix

13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.2 Bibliography
13.3 About the Publisher
13.4 Contact the Publisher
13.5 Disclaimer

List of Tables

Table 1: COVID-19 indicators (number of cases), Global and Poland, 2022
Table 2: COVID-19-related travel restrictions, Poland, 2020-22
Table 3: COVID-19 IVD Products, Poland, 2021-22
Table 4: COVID-19 vaccines trials, Poland, 2022
Table 5: COVID-19 approved vaccines, Poland, 2022
Table 6: Medical devices market, major segments ($M), Poland, 2021
Table 7: Hospital supplies market, Poland, revenue ($M) and market share (%) of major companies, 2021
Table 8: Cardiovascular devices market, Poland, revenue ($M) and market share (%) of major companies, 2021
Table 9: General surgery market, Poland, revenue ($M) and market share (%) of major companies, 2021
Table 10: Orthopedic devices market, Poland, revenue ($M) and market share (%) of major companies, 2021
Table 11: Diabetes care devices market, Poland, revenue ($M) and market share (%) of major companies, 2021
Table 12: Calculation of product cost, Poland, 2022
Table 13: Fees for filing of patent and protection, Poland, 2022
Table 14: Trade fairs, Poland, 2022

List of Figures

Figure 1: Pharmaceutical market, revenue ($B), Poland, 2013-21
Figure 2: Medical devices market, revenue ($B), Poland 2016-2021
Figure 3: Healthcare start-ups in Poland, 2022
Figure 4: Country profile, Poland, 2021
Figure 5: Pharmaceutical market, revenue ($B), Poland, 2013-21
Figure 6: Pharmaceutical market, revenue forecast ($B), Poland, 2022-26
Figure 7: Pharmaceutical exports ($B), Poland, 2014-21
Figure 8: Top export partners, Poland, 2021
Figure 9: Pharmaceutical imports ($B), Poland, 2014-21
Figure 10: Top import partners, Poland, 2021
Figure 11: Major generic drug companies, Poland, 2021
Figure 12: OTC medicines market, major distribution channels ($M), Poland, 2021
Figure 13: OTC medicines market, revenue ($B), Poland, 2014-21
Figure 14: OTC medicines market, major categories ($M), Poland, 2021
Figure 15: COVID-19 cases, Poland, 2020-22
Figure 16: COVID-19 deaths, Poland, 2020-22
Figure 17: COVID-19 stringency index (based on vaccination ratio), Poland, 2020-22
Figure 18: COVID-19 containment and health index, Poland, 2020-22
Figure 19: COVID-19 fiscal stimulus timeline, Poland, 2020-22
Figure 20: COVID-19 vaccine doses administration, number of vaccine doses administered, Poland, 2022
Figure 21: Stages of COVID-19 national vaccination program, Poland, 2021
Figure 22: COVID-19 vaccine booster doses administration, number of vaccine doses administered per 100 people, Poland, 2021-22
Figure 23: COVID-19 clinical trials count by trial status, Poland, 2021-22
Figure 24: COVID-19 clinical trials count by market category, Poland, 2021-22
Figure 25: Top COVID-19 clinical trials sponsors by trial count, Poland, 2021-22
Figure 26: Medical devices market, revenue ($B), Poland 2016-21
Figure 27: Medical devices market, revenue forecast ($B), Poland, 2022-27
Figure 28: Medical devices market, major segments (%), Poland, 2021
Figure 29: Hospital supplies market, revenue ($B), Poland, 2018-27
Figure 30: Hospital supplies market, Poland, market share of major players (%), 2021
Figure 31: Cardiovascular devices market, revenue ($M), Poland, 2018-27
Figure 32: Cardiovascular devices market, Poland, market share of major players (%), 2021
Figure 33: General surgery market, revenue ($M), Poland, 2018-27
Figure 34: General surgery market, Poland, market share of major players (%), 2021
Figure 35: Orthopedic devices market, revenue ($M), Poland, 2018-27
Figure 36: Orthopedic devices market, Poland, market share of major players (%), 2021
Figure 37: Diabetes care devices market, revenue ($M), Poland, 2018-27
Figure 38: Diabetes care devices market, Poland, market share of major players (%), 2021
Figure 39: Diagnostics market, revenue ($M), Poland, 2017-21
Figure 40: Diagnostics market, revenue forecast ($M), Poland, 2022-27
Figure 41: Medical devices market, revenue ($B) of major companies, Poland, 2021
Figure 42: Deal value and deal count, pharmaceutical market, Poland, 2019-22
Figure 43: Deal value and deal count subtypes, pharmaceutical market, Poland, 2019-22
Figure 44: Deal value and deal count, quarterly, pharmaceutical market, Poland, 2019-22
Figure 45: Top therapy areas by deal value ($M), pharmaceutical market, Poland, 2019-22
Figure 46: Top therapy areas by deal count, pharmaceutical market, Poland, 2019-22
Figure 47: M&A deals by quarter, pharmaceutical market, Poland, 2019-22 (by value and by number)
Figure 48: Deal value and deal count, medical devices market, Poland, 2019-22
Figure 49: Deal value and deal count subtypes, medical devices market, Poland, 2019-22
Figure 50: Deal value and deal count, quarterly, medical devices market, Poland, 2019-22
Figure 51: Top equipment sectors by deal value ($M), medical devices market, Poland, 2019-22
Figure 52: Top equipment sectors by deal count, medical devices market, Poland, 2019-22
Figure 53: M&A deals by quarter, medical devices market, Poland, 2019-22 (by value and by number)
Figure 54: PE deals by quarter, medical devices market, Poland, 2019-22 (by value and by number)
Figure 55: Deal value ($M) and deal count, Healthtech, Poland, 2020-22
Figure 56: Deal value ($M) based on technology themes, Healthtech, Poland, 2020-22
Figure 57: Four pillars of digital competence development program (2020-30), Poland
Figure 58: Objectives of Polish National AI Strategy, 2019-27, Poland
Figure 59: Digital Health Funding, 2021, Poland
Figure 60: Objectives of the cybersecurity strategy 2019-24, Poland
Figure 61: Organization of healthcare system, Poland, 2022
Figure 62: Public health Insurance Coverage (% of Total Population), Poland, 2012-20
Figure 63: OOP Expenditure (% of Health Spending), Poland, 2012-20
Figure 64: Health price index, Poland, 2012-21
Figure 65: Figure 65: Centralized Procedure, Poland, 2022
Figure 66: Decentralized Procedure, Poland, 2022
Figure 67: Mutual Recognition Procedure, Poland, 2022
Figure 68: Conformity Assessment of Class I Medical Devices, EU, 2022
Figure 69: Conformity Assessment of Class IIa Medical Devices, EU, 2022
Figure 70: Conformity Assessment of Class IIb Medical Devices, EU, 2022
Figure 71: Conformity Assessment of Class III Medical Devices, EU, 2022
Figure 72: Patent approval process, Poland, 2022
Figure 73: European patent approval process, EU, 2022
Figure 74: Unitary patent approval process, EU, 2022
Figure 75: Trademark approval process, Poland, 2022
Figure 76: Pharmaceutical clinical trials count by trial status, Poland, 2020-22
Figure 77: Pharmaceutical clinical trials count by indication, Poland, 2020-22
Figure 78: Pharmaceutical clinical trials count by phase, Poland, 2020-22
Figure 79: Top five pharmaceutical clinical trials sponsors by count, Poland, 2020-22
Figure 80: Medical devices clinical trials count by therapeutic areas, Poland, 2020-22al devices clinical trials count by trial status, Poland, 2020-22
Figure 81: Medical devices clinical trials count by indication, Poland, 2020-22
Figure 82: Medical devices clinical trials count by indication, Poland, 2020-22
Figure 83: Top five medical devices clinical trials sponsors by count, Poland, 2020-22
Figure 84: Strategic objectives of national medicines policy, Poland, 2018-22
Figure 85: Number of hospitals, Poland, 2013-21
Figure 86: Number of diagnostic equipment, Poland, 2012-19
Figure 87: Acute care hospital beds (per 1,000 population), Poland, 2013-21
Figure 88: Total number of hospital beds (per 1,000 population), Poland, 2013-21
Figure 89: Psychiatric care hospital beds (per 1,000 population), Poland, 2013-21
Figure 90: Immunization rate (%), Poland, 2013-21
Figure 91: Life expectancy at birth (years), Poland, 2013-20
Figure 92: CO2 emissions (million tons), Poland, 2013-21

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€1982EUR$1,995USD£1,648GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€2972EUR$2,992USD£2,471GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€3964EUR$3,990USD£3,296GBP

Scope

Reasons to Buy

Table of Contents

Related Topics

Related Reports

Poland Sterilization Equipment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032

Poland Biocompatibility Testing Services for Medical Devices Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

Medical Devices Reimbursement Market by Payer, End-User - Global Forecast 2025-2030

Implantable Medical Device Market by Product, Biologics, End User - Global Forecast 2025-2030

Wound Electrical Stimulation Devices Market - A Global and Regional Analysis : Focus on Region, Country-Level Analysis, and Competitive Landscape - Analysis and Forecast, 2023-2030